Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Inclusion Criteria: * MSKCC Histologically confirmed ovarian, fallopian tube or primary peritoneal carcinoma. * Patient has received at least one prior platinum-containing (cisplatin or carboplatin) regimen * Age ≥ 21 years old * Karnofsky Performance Status (KPS) \> or = to 70% * Adequate hematologic, hepatic and renal function as defined below: * Hemoglobin ≥ 7.0 g/dl * Absolute neutrophil count ≥ 1,000/mm3 * Platelet count ≥ 100,000/mm3 * Serum creatinine ≤ 1.5 x the upper limit of normal or calculated creatinine clearance ≥ 60 mL/min Exclusion Criteria: * Prior carboplatin or cisplatin hypersensitivity reaction * Uncontrolled intercurrent illness including infection, congestive heart failure, myocardial infarction, transient ischemic attack or stroke within 6 months. Any such conditions that have occurred in the last 6 months but are no longer active at the time of registration are not considered exclusionary. * Patients receiving other investigational agents * Patients with HIV disease will be permitted, only if they are on effective antiretroviral therapy, have a CD4 count greater than 400, and have had no opportunistic infections within the past 6 months * Pregnant or lactating women * Life expectancy of less than 12 weeks